Skip to content
2000
Volume 24, Issue 39
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Colorectal cancer (CRC) is one of the most common cancers globally and is associated with a high mortality rate. The transforming growth factor beta (TGF-β) signaling pathway plays an important role in normal intestinal tissue function, but has also been implicated in the development of CRC. MicroRNAs (miRNAs) have also recently emerged as important regulators of cancer development and progression. They act by targeting multiple signaling pathways including the TGF-β signaling pathway. There is growing evidence demonstrating that miRNAs target various components of the TGF-β signaling pathway, including TGF-β1, TGF-β2, regulatory SMADs (SMAD1, 2, 3, 5 and 9), co-mediator SMAD4, inhibitory SMADs (SMAD6 and 7) and the TGF-β receptors, and thereby alter the proliferation and migration of CRC cells. In this review, we summarize the data concerning the interaction between TGF-β signaling pathway and miRNAs with the aim to better understanding the CRC molecular mechanisms and hence better management of this disease.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612825666190110150705
2018-11-01
2025-06-19
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612825666190110150705
Loading

  • Article Type:
    Review Article
Keyword(s): atorvastatin; colorectal cancer; lipid-lowering effects; meta-analysis; safety; SLCO1B1
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test